MedPath

Mobile Phone-Based Smoking-Cessation Intervention for Smoking Parents

Not Applicable
Not yet recruiting
Conditions
Smoking Cessation
Interventions
Behavioral: 5A's/5R's advice
Other: Health warning leaflet
Behavioral: AI-powered chatbot support
Registration Number
NCT06570122
Lead Sponsor
Beijing Normal University
Brief Summary

This study aims to explore the feasibility and preliminary effectiveness of a mobile phone-based intervention tailored specifically for smoking parents.

Detailed Description

Parental smoking is associated with numerous adverse outcomes, including exposure to secondhand smoke, heightened risk of respiratory illnesses in children, and an increased likelihood that children will adopt smoking behaviors themselves. Despite awareness of these risks, many parents find it challenging to quit smoking due to stress, lack of support, and time constraints.

This randomized controlled trial (RCT) investigates the effectiveness of a mobile phone-based intervention tailored specifically for smoking parents. The intervention group will receive AI-powered chatbot cessation support, while the control group will be provided with brief cessation advice. The study aims to determine whether the AI-driven intervention is more effective in helping parents quit smoking compared to traditional brief advice.

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
All
Target Recruitment
300
Inclusion Criteria
  1. aged 18 and above, reside in Zhuhai for the next 6 months
  2. smoke at least 1 cigarette or use e-cigarettes daily
  3. have a smartphone and a WeChat account, able to use WeChat skillfully
Exclusion Criteria
  1. Smokers who have communication barrier (either physically or cognitively)
  2. Smokers who are currently participating in other SC programmes or services

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
AI chatbot support group5A's/5R's adviceAI-powered chatbot support+ 5A's/5R's advice + health warning leaflet
AI chatbot support groupAI-powered chatbot supportAI-powered chatbot support+ 5A's/5R's advice + health warning leaflet
Control group5A's/5R's advice5A's/5R's advice + health warning leaflet
AI chatbot support groupHealth warning leafletAI-powered chatbot support+ 5A's/5R's advice + health warning leaflet
Control groupHealth warning leaflet5A's/5R's advice + health warning leaflet
Primary Outcome Measures
NameTimeMethod
Self-reported 7-day point prevalence quit rate3 and 6 months follow-up

Self-reported 7-day point prevalence quit rate in the two groups

Eligibility ratebaseline

the percentage of eligible smokers out of the total number of smokers screened

Secondary Outcome Measures
NameTimeMethod
Consent ratebaseline

the percentage of eligible smokers who agree to participate out of the total number of eligible smokers

Percentage of Participant Engagement with E-Messages and Counselor Chats3 months follow-up

This outcome measures the percentage of participants who engage with the intervention by reading e-messages and responding to counselor chat messages at least once during the 3-month follow-up period.

Trial Locations

Locations (1)

Beijing Normal University

🇨🇳

Zhuhai, Guangdong, China

© Copyright 2025. All Rights Reserved by MedPath